Department of Neurosurgery, Aarhus University Hospital, Aarhus, Denmark.
Center for Experimental Neuroscience (CENSE), Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Headache. 2023 Sep;63(8):1145-1153. doi: 10.1111/head.14617. Epub 2023 Aug 21.
Chronic cluster headache (CCH) is a rare but severely debilitating primary headache condition. A growing amount of evidence suggests that occipital nerve stimulation (ONS) can offer effective treatment in patients with severe CCH for whom conventional medical therapy does not have a sufficient effect. The paresthesia evoked by conventional (tonic) stimulation can be bothersome and may thus limit therapy. Burst ONS produces paresthesia-free stimulation, but the amount of evidence on the efficacy of burst ONS as a treatment for intractable CCH is scarce.
In this case series, we report 15 patients with CCH treated with ONS at Aarhus University Hospital, Denmark, from 2013 to 2020. Nine of these received burst stimulation either as primary treatment or as a supplement to tonic stimulation. The results were assessed in terms of the frequency of headache attacks per week and their intensity on the Numeric Rating Scale, as well as the Patient Global Impression of Change (PGIC) with ONS treatment.
At a median (range) follow-up of 38 (16-96) months, 12 of the 15 patients (80%) reported a reduction in attack frequency of ≥50% (a reduction from a median of 35 to 1 attack/week, p < 0.001). Seven of these patients were treated with burst ONS. A significant reduction was also seen in maximum pain intensity. Overall, 10 patients stated a clinically important improvement in their headache condition following ONS treatment, rated on the PGIC scale. A total of 16 adverse events (nine of which were in the same patient) were registered.
Occipital nerve stimulation significantly reduced the number of weekly headache attacks and their intensity. Burst ONS seems to function well alone or as a supplement to conventional tonic ONS as a preventive treatment for CCH; however, larger prospective studies are needed to determine whether the effect can be confirmed and whether the efficacy of the two stimulation paradigms is even.
慢性丛集性头痛(CCH)是一种罕见但严重致残的原发性头痛疾病。越来越多的证据表明,对于常规药物治疗效果不佳的严重 CCH 患者,枕神经刺激(ONS)可以提供有效治疗。常规(紧张型)刺激引起的感觉异常可能会引起不适,从而限制治疗。爆发型 ONS 产生无感觉异常刺激,但关于爆发型 ONS 治疗难治性 CCH 的疗效的证据有限。
在这项病例系列研究中,我们报告了丹麦奥胡斯大学医院 2013 年至 2020 年间收治的 15 例 CCH 患者接受 ONS 治疗的情况。其中 9 例患者接受了爆发刺激治疗,或作为主要治疗方法,或作为紧张刺激的补充治疗。通过每周头痛发作次数和数字评分量表上的强度,以及患者对 ONS 治疗的整体印象变化(PGIC)来评估结果。
在中位数(范围)38(16-96)个月的随访中,15 例患者中有 12 例(80%)报告头痛发作频率降低≥50%(从中位数 35 次/周降至 1 次/周,p<0.001)。这 7 例患者接受了爆发型 ONS 治疗。最大疼痛强度也显著降低。总体而言,10 例患者在接受 ONS 治疗后报告头痛状况有临床意义的改善,根据 PGIC 量表进行评分。共登记了 16 例不良事件(其中 9 例发生在同一位患者)。
枕神经刺激显著减少了每周头痛发作的次数和强度。爆发型 ONS 似乎单独或作为常规紧张型 ONS 的补充治疗对 CCH 有效;然而,需要更大规模的前瞻性研究来确定这种效果是否可以得到证实,以及两种刺激模式的疗效是否相同。